Mammalian cell sensitivity to hyperthermia in various cell lines: a new universal and predictive description

References

• Dewhirst MW, Viglianti B, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperther. 2003;19(3):267–294.
   PubMed Web of Science ®Google Scholar
• Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperther. 2011;27(4):320–343.
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10(6):787–800.
   PubMed Web of Science ®Google Scholar
• Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperther. 2003;19(3):252–266.
   PubMed Web of Science ®Google Scholar
• Pearce JA. Comparative analysis of mathematical models of cell death and thermal damage processes. Int J Hyperther. 2013;29(4):262–280.
   PubMed Web of Science ®Google Scholar
• Viglianti BL, Dewhirst MW, Abraham JP, et al. Rationalization of thermal injury quantification methods: application to skin burns. Burns. 2014;40(5):896–902.
   PubMed Web of Science ®Google Scholar
• Palzer RJ, Heidelberger C. Studies on the quantitative biology of hyperthermic killing of HeLa cells. Cancer Res. 1973;33(2):415–421.
   PubMed Web of Science ®Google Scholar
• Gerner EW, Boone R, Connor WG, et al. A Transient Thermotolerant Survival Response Produced by Single Thermal Doses in HeLa Cells. Cancer Res. 1976;36(3):1035–1040.
   PubMed Web of Science ®Google Scholar
• Bhuyan BK, Day KJ, Edgerton CE, et al. Sensitivity of different cell lines and of different phases in the cell cycle to hyperthermia. Cancer Res. 1977;37(10):3780–3784.
   PubMed Web of Science ®Google Scholar
• Bauer KD, Henle KJ. Arrhenius analysis of heat survival curves from normal and thermotolerant cho cells. Radiat. Res. 1979;78(2):251–263.
   PubMed Web of Science ®Google Scholar
• Armour EP, McEachern D, Wang Z, et al. Sensitivity of human cells to mild hyperthermia. Cancer Res. 1993;53(12):2740–2744.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43(1):33–56.
   PubMed Web of Science ®Google Scholar
• Feng Y, Tinsley Oden J, Rylander MN. A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments. J Biomech Eng. 2008;130(4):041016.
   PubMed Web of Science ®Google Scholar
• Thompson EA, Graham E, MacNeill CM, et al. Differential response of MCF7, MDA-MB-231, and MCF 10A cells to hyperthermia, silver nanoparticles and silver nanoparticle-induced photothermal therapy. Int J Hyperth. 2014 ;30(5):312–323.
   PubMed Web of Science ®Google Scholar
• Bhuyan BK. Kinetics of cell kill by hyperthermia. Cancer Res. 1979;39(6 Pt 2):2277–2284.
   PubMed Web of Science ®Google Scholar
• Ladjimi M, Labavić D, Guilbert M, et al. Dynamical thermal dose models and dose time-profile effects. Int J Hyperther. 2019;36(1):720–729.
   Web of Science ®Google Scholar
• Sivéry A, Courtade E, Thommen Q. A minimal titration model of the mammalian dynamical heat shock response. Phys Biol. 2016;13(6):066008.
   PubMed Web of Science ®Google Scholar
• Peper A, Grimbergen CA, Spaan J, et al. A mathematical model of the hsp70 regulation in the cell. Int J Hyperther. 1998;14(1):97–124.
   PubMed Web of Science ®Google Scholar
• Ebbinghaus S, Dhar A, McDonald JD, et al. Protein folding stability and dynamics imaged in a living cell. Nat Methods. 2010;7(4):319–323.
   PubMed Web of Science ®Google Scholar
• Moré JJ. The levenberg-marquardt algorithm: implementation and theory. In: Numerical analysis. Scotland: Springer; 1978. p. 105–116.
   Google Scholar
• Geyer CJ. Markov chain monte carlo maximum likelihood. Fairfax Station (VA): Interface Foundation of North America; 1991.
   Google Scholar
• Nagaraj N, Wisniewski JR, Geiger T, et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol. 2011;7(1):548.
   PubMed Web of Science ®Google Scholar
• Finka A, Goloubinoff P. Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress and Chaperones. 2013;18(5):591–605.
   PubMed Web of Science ®Google Scholar
• The cancer proteome atlas. 2019; [cited 2019 Oct 21]. Available from: https://tcpaportal.org/tcpa/.
   Google Scholar
• Li GC, Mak JY. Induction of heat shock protein synthesis in murine tumors during the development of thermotolerance. Cancer Res. 1985;45(8):3816–3824.
   PubMed Web of Science ®Google Scholar
• Mouratidis PX, Rivens I, Civale J, et al. Relationship between thermal dose and cell death for “rapid” ablative and “slow” hyperthermic heating. Int J Hyperther. 2019;36(1):228–243.
   Web of Science ®Google Scholar
• Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperther. 1994;10(4):457–483.
   PubMed Web of Science ®Google Scholar
• Meric-Bernstam F, Mills GB. Overcoming implementation challenges of personalized cancer therapy. Nat Rev Clin Oncol. 2012;9(9):542–548.
   PubMed Web of Science ®Google Scholar
• Song C, Park H, Lee CK, et al. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperther. 2005;21(8):761–767.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC. Is cem43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperther. 2016;32(1):50–62.
   PubMed Web of Science ®Google Scholar
• Mosser DD, Caron AW, Bourget L, et al. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol. 2000;20(19):7146–7159.
   PubMed Web of Science ®Google Scholar
• Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med. 2004;200(4):425–435.
   PubMed Web of Science ®Google Scholar
• Gyrd-Hansen M, Nylandsted J, Jäättelä M. Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity. Cell Cycle. 2004;3(12):1484–1485.
   PubMed Web of Science ®Google Scholar
• Van’t Veer LJ, Dai H, Van De Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530–536.
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86–103.
   PubMed Web of Science ®Google Scholar
• Vargas-Roig LM, Fanelli MA, López LA, et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect. Prev. 1997;21(5):441–451.,
   PubMedGoogle Scholar
• Luk JM, Lam CT, Siu AF, et al. Proteomic profiling of hepatocellular carcinoma in chinese cohort reveals heat-shock proteins (hsp27, hsp70, grp78) up-regulation and their associated prognostic values. Proteomics. 2006;6(3):1049–1057.
   PubMed Web of Science ®Google Scholar
• Pfister K, Radons J, Busch R, et al. Patient survival by hsp70 membrane phenotype: association with different routes of metastasis. Cancer: Interdis Int J Am Cancer Soc. 2007;110(4):926–935.
   Google Scholar
• Gehrmann M, Specht HM, Bayer C, et al. Hsp70-a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol. 2014;9(1):131.
   PubMed Web of Science ®Google Scholar
• Calderwood S, Asea A. Targeting hsp70 induced thermotolerance for design of thermal sensitizers. Int J Hyperther. 2002;18(6):597–608.
   PubMed Web of Science ®Google Scholar
• Goloudina AR, Demidov ON, Garrido C. Inhibition of hsp70: a challenging anti-cancer strategy. Cancer Lett. 2012;325(2):117–124.
   PubMed Web of Science ®Google Scholar
• Balaburski GM, Leu JI-J, Beeharry N, et al. A modified hsp70 inhibitor shows broad activity as an anticancer agent. Mol Cancer Res. 2013;11(3):219–229.
   PubMed Web of Science ®Google Scholar
• Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by hsp70 depletion. Cancer Res. 2002;62(24):7139–7142.
   PubMed Web of Science ®Google Scholar
• Gabai VL, Yaglom JA, Wang Y, et al. Anticancer effects of targeting hsp70 in tumor stromal cells. Cancer Res. 2016;76(20):5926–5932.
   PubMed Web of Science ®Google Scholar
• Pelz JO, Vetterlein M, Grimmig T, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 2013;20(4):1105–1113.
   PubMed Web of Science ®Google Scholar
• Marquez CM, Sneed PK, Li GC, et al. Hsp 70 synthesis in clinical hyperthermia patients: preliminary results of a new technique. Int J Radiat Oncol Biol Phys. 1994;28(2):425–430.
   PubMed Web of Science ®Google Scholar
• Liu FF, Miller N, Levin W, et al. The potential role of hsp70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. Int J Hyperther. 1996;12(2):197–208.
   PubMed Web of Science ®Google Scholar
• Guilbert M, Anquez F, Pruvost A, et al. Protein level variability determines phenotypic heterogeneity in proteotoxic stress response. FEBS J. 2020. doi:10.1111/febs.15297
   PubMed Web of Science ®Google Scholar
• Neuhaus-Steinmetz U, Skrandies S, Rensing L. Heat shock protein synthesis is affected by intracellular ph: inhibition by monensin-induced alkalosis in c6 rat glioma cells. Brain Res. 1996;724(1):16–24.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Influence of extracellular ph on the viability and morphology of tumor cells exposed to hyperthermia. J Natl Cancer Inst. 1976;56(6):1243–1250.
   PubMedGoogle Scholar
• Mizzen LA, Welch WJ. Characterization of the thermotolerant cell. i. effects on protein synthesis activity and the regulation of heat-shock protein 70 expression. J Cell Biol. 1988;106(4):1105–1116.
   PubMed Web of Science ®Google Scholar